title: Trk receptors function as rapid retrograde signal carriers in the adult nervous system.
abstract: During development target-derived neurotrophins promote the survival of neurons. However, mature neurons no longer depend on the target for survival. Do target-derived neurotrophins retain retrograde signaling functions in mature neurons, and, if so, how are they executed? We addressed this question by using a phosphotyrosine-directed antibody to locate activated Trk receptors in adult rat sciatic nerve. We show that catalytically active Trk receptors are located within the axon of adult rat sciatic nerve and that they are distributed throughout the length of the axons. These catalytically active receptors are phosphorylated on tyrosine at a position that couples them to the signal-generating proteins Ras and PI3 kinase. Neurotrophin applied at sciatic nerve terminals increases both catalytic activity and phosphorylation state of Trk receptors at distant points within the axons. Trk activation initiated at the nerve terminals propagates through the axon toward the nerve cell body at an initial rate that exceeds that of conventional vesicular transport. However, our data suggest that this rapid signal is nevertheless vesicle-associated. Thus, in mature nerves, activated Trk receptors function as rapid retrograde signal carriers to execute remote responses to target-derived neurotrophins.
authors.affiliation: Dana-Farber Cancer Institute and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: A
authors.initials: A
authors.lastname: Bhattacharyya
authors.forename: F L
authors.initials: FL
authors.lastname: Watson
authors.forename: T A
authors.initials: TA
authors.lastname: Bradlee
authors.forename: S L
authors.initials: SL
authors.lastname: Pomeroy
authors.forename: C D
authors.initials: CD
authors.lastname: Stiles
authors.forename: R A
authors.initials: RA
authors.lastname: Segal
mesh_terms: D016475:3T3 Cells; D000107:Acetylation; D000818:Animals; D000906:Antibodies / Q000276:immunology; D001370:Axonal Transport / Q000187:drug effects / Q000502:physiology*; D001665:Binding Sites; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology; D002384:Catalysis; D008297:Male; D051379:Mice; D010748:Phosphopeptides / Q000276:immunology; D011518:Proto-Oncogene Proteins / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology*; D020917:Receptor, trkA; D020813:Receptor, trkB; D020812:Receptor, trkC; D017475:Receptors, Nerve Growth Factor / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D018909:src Homology Domains / Q000276:immunology
chemical_list: D000906:Antibodies; D019208:Brain-Derived Neurotrophic Factor; D010748:Phosphopeptides; D011518:Proto-Oncogene Proteins; D017475:Receptors, Nerve Growth Factor; D020794:Receptor Protein-Tyrosine Kinases; D020917:Receptor, trkA; D020813:Receptor, trkB; D020812:Receptor, trkC